Abridge Acquires Altrina to Build Agentic AI Workflow Tools

Abridge expands beyond scribing with workflow automation acquisition

Abridge, a leading clinical documentation AI company, has acquired Altrina, a startup that builds AI agents to automate multi-step workflows across healthcare systems. The deal brings aboard Altrina's three-person founding team, including co-founders Mo Nasir and Harvey Hu, along with founding engineer Karthik Prasad.

According to details first reported by TechTarget, Altrina launched in 2025 with backing from startup accelerator Y Combinator. The company's platform creates AI agents capable of navigating multiple systems and executing complex workflows while maintaining compliance with SOC 2 Type I & II, GDPR, and HIPAA standards. The platform also maintains audit trails of all actions, a critical requirement for healthcare deployment.

Why it matters

This acquisition signals a strategic shift from ambient documentation toward agentic AI that can act autonomously across clinical systems. While AI scribes capture and summarize conversations, workflow agents can execute tasks like placing orders, updating multiple records, and coordinating care activities. For healthcare organizations already stretched thin administratively, this represents a path toward automation that goes beyond note-taking to address the broader burden of multi-system data entry and care coordination.

Technical expertise meets clinical scale

The Altrina team brings specific experience building browser and computer-use agents, automating workflows across electronic health records, and developing production infrastructure. Abridge Chief Technology Officer San Oo emphasized that healthcare AI success requires more than advanced models alone.

"Healthcare is one of the most demanding environments in which to build AI, and success won't come from models alone," Oo stated. "It will come from teams that combine deep AI expertise with an understanding of clinical workflows, enterprise deployment, security, and the realities of healthcare."

Abridge plans to integrate this workflow automation expertise with its existing clinical documentation platform, which already supports clinicians before, during, and after patient visits through pre-visit notes, ambient documentation, and follow-up summaries.

Rapid expansion across the care continuum

The acquisition follows a period of significant growth for Abridge. The company recently added clinical decision support features drawing on evidence from partnerships with the American Diabetes Association, American Academy of Family Physicians, The New England Journal of Medicine, and the JAMA network.

Abridge has also secured a strategic investment from pharmaceutical company Eli Lilly to support research applications, including identifying potential clinical trial candidates. Additionally, the company is integrating its platform into AI-enabled smart room technology through partnerships with Artisight and hellocare.ai.

Abridge CEO Shiv Rao has described the company's platform as a "clinical conversation foundation model" designed to support the full spectrum of clinician workflows, not just documentation capture.

The acquisition details were first reported by TechTarget's SearchHealthIT.